Loading…
Designer Anabolic Steroid Control Act of 2014
Legislative Progress
Introduced
February 11, 2014
Latest Action
February 11, 2014
Primary Sponsor
Sheldon WhitehouseDemocratic(RI)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,002 other S bills in the 113th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (17)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2015 · fourth_quarter · Food Industry (safety, labeling, etc.)
1) Adequate FDA funding to fully enforce DSHEA, inspect dietary supplement manufacturers, take enforcement action against clear violations of law and carryout other required regulatory activities 2) New Dietary Ingredient Guidance - prompt publication of second draft guidance of this document from FDA 3) Full implementation by DEA of HR/4771 and S2012 Designer Anabolic Steroid Control Act 4) Shared information about key nutrient shortfalls based on NHANES data
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · third_quarter · Food Industry (safety, labeling, etc.)
1) Adequate FDA funding to fully enforce DSHEA, inspect dietary supplement manufacturers, take enforcement action against clear violations of law and carryout other required regulatory activities 2) New Dietary Ingredient Guidance - prompt publication of second draft guidance of this document from FDA 3) Full implementation by DEA of HR/4771 and S2012 Designer Anabolic Steroid Control Act 4) Shared information about key nutrient shortfalls based on NHANES data
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · second_quarter · Food Industry (safety, labeling, etc.)
1) Adequate FDA funding to fully enforce DSHEA, inspect dietary supplement manufacturers, take enforcement action against clear violations of law and carryout other required regulatory activities 2) New Dietary Ingredient Guidance - prompt publication of second draft guidance of this document from FDA 3) Full implementation by DEA of HR/4771 and S2012 Designer Anabolic Steroid Control Act
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Alcohol and Drug Abuse
S.2012/H.R.4771: Designer Anabolic Steroid Control Act. Reauthorization of the U.S. Anti-Doping Agency. Funding for U.S. Anti-Doping Agency.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · first_quarter · Food Industry (safety, labeling, etc.)
1) Adequate FDA funding to fully enforce DSHEA, inspect dietary supplement manufacturers, take enforcement action against clear violations of law and carryout other required regulatory activities 2) New Dietary Ingredient Guidance - prompt publication of second draft guidance of this document from FDA 3) Full implementation by DEA of HR/4771 and S2012 Designer Anabolic Steroid Control Act
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 1385, to amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the safe use of cosmetics, and for other purposes. H.R. 3990, to prevent and mitigate identity theft, to ensure privacy, to provide notice of security breaches and to enhance criminal penalties, law enforcement assistance and other protections against security breaches, fraudulent access and misuse of personally identifiable information. H.R. 4148, to phase out cosmetic animal testing and the sale of cosmetics tested on animals. H.R. 4215, to strengthen privacy and data security. H.R. 4250, to amend the Federal Food, Drug and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes. H.R. 4381, to protect the privacy of individuals' personal genetic information and other personal identifier information. H.R. 4400, to protect consumers by requiring reasonable security policies and procedures to protect data containing personal information, and to provide for nationwide notice in the event of a security breach; to Energy & Commerce. HR 4759, the Designer Anabolic Steroid Control Act of 2014. HR 4883, the Microbead-Free Waters Act of 2014. HR 4974, the End Operation Choke Point Act of 2014. S. 1193, to require certain entities that collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes S. 1897, to prevent and mitigate identity theft, to ensure privacy, to provide notice of security breaches and to enhance criminal penalties, law enforcement assistance and other protections against security breaches, fraudulent access and misuse of personally identifiable information; to Judiciary. S. 1903, to provide greater fee disclosures for consumers who have prepaid cards, and for other purposes. S. 1927, to protect information relating to consumers, to require notice of security breaches, and for other purposes. S. 1976, to protect consumers by requiring reasonable security policies and procedures to protect data containing personal information and to provide for nationwide notice in the event of a breach of security. S. 1995, to protect consumers by mitigating the vulnerability of personally identifiable information to theft through a security breach, providing notice and remedies to consumers in the wake of such a breach, holding companies accountable for preventable breaches, facilitating the sharing of post-breach technical information between companies and enhancing criminal and civil penalties and other protections against the unauthorized collection or use of personally identifiable information. S. 2012, to amend the Controlled Substances Act to more effectively regulate anabolic steroids. S. 2141, to amend the Federal Food, Drug and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes. S. 2572, the Ban Poisonous Additives Act of 2014. S. 2902 . Microbead-Free Waters Act of 2014
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Alcohol and Drug Abuse
S. 2012/H.R.4771: Designer Anabolic Steroid Control Act of 2014. Reauthorization of the U.S. Anti-Doping Agency. Funding for USADA.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
S. 2012- Designer Anabolic Steroid Control Act of 2014
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2014 · fourth_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. Monitor legislative and administrative action related to point-of-care instruments. Monitor legislative and administrative action related to streamlined pathways to market for breakthrough technologies. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor activities related to House Energy and Commerce Committees 21st Century Cures Initiative. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act. S. 2917, Adding Ebola to the FDA Priority Review Voucher Program Act. H.R. 3969, Preventing Abuse of Cough Treatments Act of 2014 or the PACT Act. S. 644, Preventing Abuse of Cough Treatments Act of 2013 or the PACT Act.
Client expense: $1,240,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2014 · fourth_quarter · Food Industry (safety, labeling, etc.)
Dietary Supplements - S. 1425 - Dietary Supplement Labeling Act. Expands registration requirements for dietary supplement manufacturing or processing facilities; requires development of a definition of "conventional food," including foods marketed as dietary supplements; all sections. H.R. 4771/S. 2012 - Designer Anabolic Steroid Control Act (DASCA). Food and Drug Administration (FDA) regulation of anabolic steroids; all sections. Became Public Law 113-260. Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues."
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Energy/Nuclear
Issues related to exploration and development of Alaska offshore oil and gas leases, including lease terms, Supplemental EIS, permits, regulations; Senate Passage of KXL legislation; Issues related to Shell's Alaska Venture, specifically Noble Corp; Issues related to Arctic and Alaska OCS operating regulations/requirements; Issues related to draft 2017-2022 OCS Leasing Plan; Issues related to Shell's Alaska Venture, specifically regulatory issues; Issues related to offshore access - Atlantic and EGOM (no specific bill); General offshore energy and safety issues; Issues related to the implementation of findings of DOI 60-day review of Shell's 2012 season.
Client expense: $1,580,000 · Firm income: Not reported
Government targets: American Battle Monuments Commission, Commerce, Dept of (DOC), Council on Environmental Quality (CEQ), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Marine Mammal Commission, Natl Oceanic & Atmospheric Administration (NOAA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Coast Guard (USCG), White House Office
2014 · fourth_quarter · Aviation/Airlines/Airports
Opposed H.R. 4156, the Transparent Airfares Act, which would overturn USDOT's 2012 full-fare advertising rule. Discussed USDOT rulemaking on airline ancillary fee transparency.
Client expense: Not reported · Firm income: Not reported
Government targets: SENATE
2014 · third_quarter · Food Industry (safety, labeling, etc.)
Dietary SupplementsS. 1425 - Dietary Supplement Labeling Act. Expands registration requirements for dietary supplement manufacturing or processing facilities; requires development of a definition of "conventional food," including foods marketed as dietary supplements; all sections. H.R. 4771/S. 2012 - Designer Anabolic Steroid Control Act (DASCA). Food and Drug Administration (FDA) regulation of anabolic steroids; all sections. Became Public Law 113-260. Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues."
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Food Industry (safety, labeling, etc.)
S. 2012 Designer Anabolic Steroid Control Act of 2014 H.R. 4771 Designer Anabolic Steroid Control Act of 2014
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Insurance
HR 1064; HR 1155; S 534; S 1926 National Association of Registered Agent and Brokers Reform Act; Issue: reducing costs and administrative difficulties associated with reciprocal licensing of multi-state insurance agents. We support these bills. HR 508 Reauthorize the Terrorism Risk Insurance Act (TRIA) for 5 years; HR 1945 and HR 2146 (10 year TRIA ext); S. 2244 (7 years) support these bills; HR 4871 House Fin Services Comm TRIA bill (5 years) concern with program changesHR 4510/S 2012/S 2270 Insurance Capital Standards Clarification Act of 2014 and S 1369 Capital Standards for the Business of Insurance, support these bills to provide flexibility for the Federal Reserve in setting insurance capital requirements. HR 4669 - Servicemembers Insurance Relief Act; monitoring issue to see if new requirements will be established H Res 735/S Res 561 Expressing concern about the lack of transparency at International Association of Insurance Supervisors meetings; support these resolutions
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Food Industry (safety, labeling, etc.)
Dietary supplement and food safety issues. Monitor the following: New Dietary Ingredient Guidance issues. H.R.1699/S.809, Genetically Engineered Food Right-to-Know Act, GMO food issues. Food safety modernization regulations, generally. S.1425, Dietary Supplement Labeling Act, Regulations of Dietary Supplements H.R.4771/S.2012, Designer Anabolic Steroid Control Act (DASCA), Dietary supplement enforcement issues.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Food Industry (safety, labeling, etc.)
HR 4771/S2012 - the Designer Anabolic Steroid Control Act. I met with various members of Congress and staff to discuss Pharmavite support for this proactive measure.
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding dietary supplements: H.R.4771/S.2012, Designer Anabolic Steroid Control Act Dehydroepiandrosterone Abuse Reduction Act Dimethylamylamine (DMAA)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Law Enforcement/Crime/Criminal Justice
S. 2012- Designer Anabolic Steroid Control Act of 2014
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2014 · third_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. Monitor legislative and administrative action related to point-of-care instruments. Monitor legislative and administrative action related to streamlined pathways to market for breakthrough technologies. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor activities related to House Energy and Commerce Committees 21st Century Cures Initiative. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 1528, Veterinary Medicine Mobility Act of 2014. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act.
Client expense: $1,450,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2014 · second_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 1528, Veterinary Medicine Mobility Act of 2014. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act.
Client expense: $1,360,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2014 · third_quarter · Consumer Issues/Safety/Products
H.R. 1385, to amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the safe use of cosmetics, and for other purposes. H.R. 3990, to prevent and mitigate identity theft, to ensure privacy, to provide notice of security breaches and to enhance criminal penalties, law enforcement assistance and other protections against security breaches, fraudulent access and misuse of personally identifiable information. H.R. 4148, to phase out cosmetic animal testing and the sale of cosmetics tested on animals. H.R. 4215, to strengthen privacy and data security. H.R. 4250, to amend the Federal Food, Drug and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes. H.R. 4381, to protect the privacy of individuals' personal genetic information and other personal identifier information. H.R. 4400, to protect consumers by requiring reasonable security policies and procedures to protect data containing personal information, and to provide for nationwide notice in the event of a security breach; to Energy & Commerce. HR 4759, the Designer Anabolic Steroid Control Act of 2014. HR 4883, the Microbead-Free Waters Act of 2014. HR 4974, the End Operation Choke Point Act of 2014. S. 1193, to require certain entities that collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes S. 1897, to prevent and mitigate identity theft, to ensure privacy, to provide notice of security breaches and to enhance criminal penalties, law enforcement assistance and other protections against security breaches, fraudulent access and misuse of personally identifiable information; to Judiciary. S. 1903, to provide greater fee disclosures for consumers who have prepaid cards, and for other purposes. S. 1927, to protect information relating to consumers, to require notice of security breaches, and for other purposes. S. 1976, to protect consumers by requiring reasonable security policies and procedures to protect data containing personal information and to provide for nationwide notice in the event of a breach of security. S. 1995, to protect consumers by mitigating the vulnerability of personally identifiable information to theft through a security breach, providing notice and remedies to consumers in the wake of such a breach, holding companies accountable for preventable breaches, facilitating the sharing of post-breach technical information between companies and enhancing criminal and civil penalties and other protections against the unauthorized collection or use of personally identifiable information. S. 2012, to amend the Controlled Substances Act to more effectively regulate anabolic steroids. S. 2141, to amend the Federal Food, Drug and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes. S. 2572, the Ban Poisonous Additives Act of 2014. S. 2902 . Microbead-Free Waters Act of 2014
Client expense: $110,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Alcohol and Drug Abuse
S. 2012/H.R.4771: Designer Anabolic Steroid Control Act of 2014. Reauthorization of the U.S. Anti-Doping Agency.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Food Industry (safety, labeling, etc.)
H.R. 4800/S.2389, FY2015 Appropriations for the Department of Agriculture and Related Agencies. Increased funding for regulation of dietary supplements. H.R. 4771/S.2012, The Designer Anabolic Steroids Control Act. Full implementation of laws and regulations pertaining to dietary supplements. Addressing nutrient shortfalls among Americans (no specific legislation).
Client expense: Not reported · Firm income: $36,000
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
H.R. 4800/S.2389, FY2015 Appropriations for the Department of Agriculture and Related Agencies. Increased funding for regulation of dietary supplements. H.R. 4771/S.2012, The Designer Anabolic Steroids Control Act. Full implementation of laws and regulations pertaining to dietary supplements. Addressing nutrient shortfalls among Americans (no specific legislation).
Client expense: Not reported · Firm income: $36,000
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
H.R. 4771/S.2012, The Designer Anabolic Steroids Control Act. Draft legislation regarding regulation of cosmetics and cosmetics ingredients. Support for full implementation and enforcement of Dietary Supplement Health and Education Act.
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Food Industry (safety, labeling, etc.)
H.R. 4771/S.2012, The Designer Anabolic Steroids Control Act. Draft legislation regarding regulation of cosmetics and cosmetics ingredients. Support for full implementation and enforcement of Dietary Supplement Health and Education Act.
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Insurance
HR 1064; HR 1155; S 534; S 1926 National Association of Registered Agent and Brokers Reform Act; Issue: reducing costs and administrative difficulties associated with reciprocal licensing of multi-state insurance agents. We support these bills. HR 508 Reauthorize the Terrorism Risk Insurance Act (TRIA) for 5 years; HR 1945 and HR 2146 (10 year TRIA ext); S. 2244 (7 years) support these bills; HR 4871 House Fin Services Comm TRIA bill (5 years) concern with program changesHR 605 Insurance Consumer Protection and Solvency Act; take insurers out of FDIC liquidation process; support HR 4510/S 2012/S 2270 Insurance Capital Standards Clarification Act of 2014 and S 1369 Capital Standards for the Business of Insurance, support these bills to provide flexibility for the Federal Reserve in setting insurance capital requirements. HR 4669 - Servicemembers Insurance Relief Act; monitoring issue to see if new requirements will be established H Res 735/S Res 561 Expressing concern about the lack of transparency at International Association of Insurance Supervisors meetings; support these resolutions
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Consumer Issues/Safety/Products
S. 2012 - Designer Anabolic Steroid Control Act, a bill to amend the Controlled Substances Act to more effectively regulate anabolic steroids; all provisions relating to dietary supplements H.R. 4771 - Designer Anabolic Steroid Control Act, a bill to amend the Controlled Substances Act to more effectively regulate anabolic steroids; all provisions relating to dietary supplements
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Energy/Nuclear
General offshore energy and safety issues; Issues related to offshore access to the Atlantic and EGOM (no specific bill); Issues related to THUD Appropriations (LNG facility); Issues related to offshore safety regulations; Issues related to DOI's Alaska specific OCS regulations; Issues related to the implementation of findings of DOI 60-day review of Shell's 2012 season; Issues related to outlook for Shell's Alaska venture, including lease terms, Supplemental EIS, permits, regulations; General issues as related to Arctic OCS operating regulations/requirements and other general Arctic policy issues; Potential appropriations language for LNG.
Client expense: $2,350,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Marine Mammal Commission, Natl Oceanic & Atmospheric Administration (NOAA), Natl Science Foundation (NSF), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Coast Guard (USCG), White House Office
2014 · third_quarter · Aviation/Airlines/Airports
Opposed the Transparent Airfares Act (H.R. 4156), which would overturn USDOT's 2012 full-fare advertising rule. Supported transparency and "transactability" (purchasable by travel agents) in airline ancillary fees via USDOT's aviation consumer protection rulemaking. Supported rationalizing the regulatory burden on travel agents who sell air travel through the FAA reauthorization bill.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES
2014 · third_quarter · Food Industry (safety, labeling, etc.)
Dietary SupplementsS. 1425 - Dietary Supplement Labeling Act. Expands registration requirements for dietary supplement manufacturing or processing facilities; requires development of a definition of "conventional food," including foods marketed as dietary supplements; all sections. H.R. 4771/S. 2012 - Designer Anabolic Steroid Control Act (DASCA). Food and Drug Administration (FDA) regulation of anabolic steroids; all sections. Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues."
Client expense: $220,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding dietary supplements: H.R.4771/S.2012, Designer Anabolic Steroid Control Act Dehydroepiandrosterone Abuse Reduction Act Dimethylamylamine (DMAA)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Food Industry (safety, labeling, etc.)
Monitor the following: Dietary supplement and food safety issues. New Dietary Ingredient Guidance issues. H.R.1699/S.809, Genetically Engineered Food Right-to-Know Act, GMO food issues. National Toxicology program, Herb and botanical research and development issues. Food safety modernization regulations, generally. S.1425, Dietary Supplement Labeling Act, Regulations of Dietary Supplements H.R.4771/S.2012, Designer Anabolic Steroid Control Act (DASCA), Dietary supplement enforcement issues.
Client expense: Not reported · Firm income: $10,000
2014 · third_quarter · Food Industry (safety, labeling, etc.)
S. 2012 Designer Anabolic Steroid Control Act of 2014 H.R. 4771 Designer Anabolic Steroid Control Act of 2014
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Law Enforcement/Crime/Criminal Justice
H.R.4771/S.2012, Designer Anabolic Steroid Control Act Dehydroepiandrosterone Abuse Reduction Act Dimethylamylamine (DMAA)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Consumer Issues/Safety/Products
H.R. 1385, to amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the safe use of cosmetics, and for other purposes.H.R. 3990, to prevent and mitigate identity theft, to ensure privacy, to provide notice of security breaches and to enhance criminal penalties, law enforcement assistance and other protections against security breaches, fraudulent access and misuse of personally identifiable information. H.R. 4148, to phase out cosmetic animal testing and the sale of cosmetics tested on animals. H.R. 4215, to strengthen privacy and data security. H.R. 4250, to amend the Federal Food, Drug and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes. H.R. 4381, to protect the privacy of individuals' personal genetic information and other personal identifier information. H.R. 4400, to protect consumers by requiring reasonable security policies and procedures to protect data containing personal information, and to provide for nationwide notice in the event of a security breach; to Energy & Commerce. HR 4759, the Designer Anabolic Steroid Control Act of 2014. HR 4883, the Microbead-Free Waters Act of 2014. HR 4974, the End Operation Choke Point Act of 2014. S. 1193, to require certain entities that collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes S. 1897, to prevent and mitigate identity theft, to ensure privacy, to provide notice of security breaches and to enhance criminal penalties, law enforcement assistance and other protections against security breaches, fraudulent access and misuse of personally identifiable information; to Judiciary. S. 1903, to provide greater fee disclosures for consumers who have prepaid cards, and for other purposes. S. 1927, to protect information relating to consumers, to require notice of security breaches, and for other purposes. S. 1976, to protect consumers by requiring reasonable security policies and procedures to protect data containing personal information and to provide for nationwide notice in the event of a breach of security. S. 1995, to protect consumers by mitigating the vulnerability of personally identifiable information to theft through a security breach, providing notice and remedies to consumers in the wake of such a breach, holding companies accountable for preventable breaches, facilitating the sharing of post-breach technical information between companies and enhancing criminal and civil penalties and other protections against the unauthorized collection or use of personally identifiable information. S. 2012, to amend the Controlled Substances Act to more effectively regulate anabolic steroids. S. 2141, to amend the Federal Food, Drug and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes. S. 2572, the Ban Poisonous Additives Act of 2014.
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2014 · second_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 1528, Veterinary Medicine Mobility Act of 2014. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act.
Client expense: $1,340,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2014 · second_quarter · Law Enforcement/Crime/Criminal Justice
S. 2012- Designer Anabolic Steroid Control Act of 2014
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2014 · second_quarter · Energy/Nuclear
Issues related to exploration and development of Alaska offshore oil and gas leases, including lease terms, permits, Supplemental EIS, and permits; Legislation regarding approval of the Keystone XL Pipeline, including S. 2554 & S. 2280; S. 2136 - A bill to ensure that oil transported through the Keystone XL pipeline into the United States is used to reduce United States dependence on Middle Eastern oil, all provisions; H.R. 3885 - GROWTH Act, all provisions;Issues related to simplifying and clarifying regulatory requirements for offshore oil and gas activity, including NEPA requirements; H.R. 6 - Domestic Prosperity and Global Freedom Act, all provisions; Issues related to offshore access in the Atlantic and EGOM (no specific legislation); Issues related to offshore safety regulations (no specific legislation); General Arctic policy issues; S. 2314 - Removing Repeated Executive Delays to Transboundary Approvals of Pipelines and Engineering Act, all provisions; Issues regarding the implementation of findings of DOI 60-day review of Shell's 2012 season;
Client expense: $2,060,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Marine Mammal Commission, Natl Oceanic & Atmospheric Administration (NOAA), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Coast Guard (USCG), White House Office
2014 · second_quarter · Food Industry (safety, labeling, etc.)
Dietary SupplementsS. 1425 - Dietary Supplement Labeling Act. Expands registration requirements for dietary supplement manufacturing or processing facilities; requires development of a definition of "conventional food," including foods marketed as dietary supplements; all sections. H.R. 4771/S. 2012 - Designer Anabolic Steroid Control Act (DASCA). Food and Drug Administration (FDA) regulation of anabolic steroids; all sections. Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues."
Client expense: $230,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Law Enforcement/Crime/Criminal Justice
Support for H.R. 4771/S.2012 the Designer Anabolic Steroids Control Act.
Client expense: Not reported · Firm income: $36,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Law Enforcement/Crime/Criminal Justice
Support for H.R. 4771/S.2012, the Designer Anabolic Steroids Control Act.
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
Full implementation and enforcement of laws and regulations related to dietary supplements. Support for H.R. 4771/S.2012, the Designer Anabolic Steroids Control Act.
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Insurance
HR 1064; HR 1155; S 534; S 1926 National Association of Registered Agent and Brokers Reform Act; Issue: reducing costs and administrative difficulties associated with reciprocal licensing of multi-state insurance agents. We support these bills. HR 508 Reauthorize the Terrorism Risk Insurance Act (TRIA) for 5 years; HR 1945 and HR 2146 (10 year TRIA ext); S. 2244 (7 years) support these bills; HR 4871 House Fin Services Comm TRIA bill (5 years) concern with program changesHR 605 Insurance Consumer Protection and Solvency Act; take insurers out of FDIC liquidation process; support HR 4510/S 2012 Insurance Capital Standards Clarification Act of 2014 and S 1369 Capital Standards for the Business of Insurance, support these bills to provide flexibility for the Federal Reserve in setting insurance capital requirements. HR 4669 - Servicemembers Insurance Relief Act; monitoring issue to see if new requirements will be established
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Aviation/Airlines/Airports
Opposed the Transparent Airfares Act (H.R. 4156), which would overturn USDOT's 2012 full-fare advertising rule.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Consumer Issues/Safety/Products
S. 2012 - Designer Anabolic Steroid Control Act, a bill to amend the Controlled Substances Act to more effectively regulate anabolic steroids; all provisions relating to dietary supplements H.R. 4771 - Designer Anabolic Steroid Control Act, a bill to amend the Controlled Substances Act to more effectively regulate anabolic steroids; all provisions relating to dietary supplements
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Food Industry (safety, labeling, etc.)
New Dietary Ingredient Regulation S. 2012 Designer Anabolic Steroid Control Act of 2014 H.R. 4771 Designer Anabolic Steroid Control Act of 2014
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding dietary supplements: H.R.4771/S.2012, Designer Anabolic Steroid Control Act Dehydroepiandrosterone Abuse Reduction Act Dimethylamylamine (DMAA)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Food Industry (safety, labeling, etc.)
Dietary supplement and food safety issues. Monitor New Dietary Ingredient Guidance issues. H.R.1699/S.809, Genetically Engineered Food Right-to-Know Act, GMO food issues. National Toxicology program, Monitor herb and botanical research and development issues. Food safety modernization regulations, generally. S.1425, Dietary Supplement Labeling Act, Regulations of Dietary Supplements H.R.4771/S.2012, Designer Anabolic Steroid Control Act (DASCA), Dietary supplement enforcement issues.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE